A 3-DIMENSIONAL MICROORGAN CULTURE SYSTEM OPTIMIZED FOR INVITRO GROWTH OF HUMAN-MALIGNANT BRAIN-TUMORS

被引:9
作者
JUNG, HW
BERENS, ME
KROUWER, HGJ
ROSENBLUM, ML
机构
[1] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT NEUROL SURG,BRAIN TUMOR RES CTR,SAN FRANCISCO,CA 94143
[2] SEOUL NATL UNIV,COLL MED,DEPT NEUROSURG,SEOUL 151,SOUTH KOREA
关键词
CHEMOTHERAPY; GLIOMA; MACROPHAGE; MICROORGAN CULTURE; XENOGRAFT;
D O I
10.1227/00006123-199109000-00009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A brain tumor is composed not only of tumor cells, but also of normal glial, mesenchymal, endothelial, and microglial cells, as well as lymphocytes and macrophages. Therefore, homogeneous cultures of tumor cells, currently used for chemosensitivity testing, do not accurately model in situ tumors. We have developed an in vitro growth assay for brain tumors that includes normal host cells and is potentially useful for studies of chemotherapy and biological response modifiers. Human glioblastoma xenografts (U251-MG) were resected from mice, minced, and explanted into agarose coated culture wells. After 5 to 7 days, microtumors emerged as expanding spheroids, which grew most efficiently in minimum essential medium supplemented with 20% fetal calf serum, 90% of which was replaced on alternate days. The growth rate and bromodeoxyuridine labeling index were similar in the microtumors and the xenografts, and light microscopy revealed highly cellular, pleomorphic tumors with high mitotic activity in both. Immunohistochemical studies also demonstrated the persistence of macrophages in both xenografts and microtumors. Microtumors treated for 2 hours with 75-mu-mol/L 1,3-bis-(2-chloroethyl)-1-nitrosourea showed a growth delay of 1.5 days; no effects were observed after treatment with lower doses. This in vitro system for brain tumor culture may provide a useful technique for the study of new therapies as an alternative to in vivo xenograft studies using immunodeficient animals.
引用
收藏
页码:390 / 398
页数:9
相关论文
共 46 条
[21]   CELL KINETIC-STUDIES OF INSITU HUMAN-BRAIN TUMORS WITH BROMODEOXYURIDINE [J].
HOSHINO, T ;
NAGASHIMA, T ;
MUROVIC, J ;
LEVIN, EM ;
LEVIN, VA ;
RUPP, SM .
CYTOMETRY, 1985, 6 (06) :627-632
[22]   CYTO-TOXIC DRUG PENETRATION STUDIES IN MULTICELLULAR TUMOR SPHEROIDS [J].
KERR, DJ ;
WHELDON, TE ;
HYDNS, S ;
KAYE, SB .
XENOBIOTICA, 1988, 18 (06) :641-648
[23]  
KORNBLITH PL, 1977, CANCER, V47, P255
[24]  
MILLER BE, 1981, CANCER RES, V41, P4378
[25]  
MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
[26]   RAPID DETECTION OF S-PHASE CELLS BY ANTI-BROMODEOXYURIDINE MONOCLONAL-ANTIBODY IN 9L BRAIN-TUMOR CELLS-INVITRO AND INSITU [J].
NAGASHIMA, T ;
HOSHINO, T .
ACTA NEUROPATHOLOGICA, 1985, 66 (01) :12-17
[27]   CELL-KINETICS STUDIES OF HUMAN-BRAIN TUMORS BY INVITRO LABELING USING ANTI-BUDR MONOCLONAL-ANTIBODY [J].
NISHIZAKI, T ;
ORITA, T ;
SAIKI, M ;
FURUTANI, Y ;
AOKI, H .
JOURNAL OF NEUROSURGERY, 1988, 69 (03) :371-374
[28]   MACROPHAGES AND MICROGLIA IN THE NERVOUS-SYSTEM [J].
PERRY, VH ;
GORDON, S .
TRENDS IN NEUROSCIENCES, 1988, 11 (06) :273-277
[29]  
ROSENBLUM ML, 1978, CANCER, V41, P2305, DOI 10.1002/1097-0142(197806)41:6<2305::AID-CNCR2820410632>3.0.CO
[30]  
2-U